Absence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal System
Open Access
- 13 February 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 5 (3) , e39
- https://doi.org/10.1371/journal.pbio.0050039
Abstract
Support of ageing neurons by endogenous neurotrophic factors such as glial cell line–derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) may determine whether the neurons resist or succumb to neurodegeneration. GDNF has been tested in clinical trials for the treatment of Parkinson disease (PD), a common neurodegenerative disorder characterized by the loss of midbrain dopaminergic (DA) neurons. BDNF modulates nigrostriatal functions and rescues DA neurons in PD animal models. The physiological roles of GDNF and BDNF signaling in the adult nigrostriatal DA system are unknown. We generated mice with regionally selective ablations of the genes encoding the receptors for GDNF (Ret) and BDNF (TrkB). We find that Ret, but not TrkB, ablation causes progressive and adult-onset loss of DA neurons specifically in the substantia nigra pars compacta, degeneration of DA nerve terminals in striatum, and pronounced glial activation. These findings establish Ret as a critical regulator of long-term maintenance of the nigrostriatal DA system and suggest conditional Ret mutants as useful tools for gaining insights into the molecular mechanisms involved in the development of PD. What does a neuron need to survive? Our body produces its own survival factors for neurons, so-called neurotrophic factors, which have additional roles in neuron differentiation, growth, and function. Declining production of a neurotrophic factor or impaired signal transduction in ageing neurons may contribute to pathological neurodegeneration in humans. Glial cell line–derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) have been suggested as survival factors for midbrain dopaminergic neurons, a group of neurons primarily affected in Parkinson disease. To investigate the physiological requirements for GDNF and BDNF to establish and maintain an important output pathway of these neurons—the nigrostriatal pathway—in the intact brain, we generated mutant mice with regionally selective ablations of the receptors for these survival factors, Ret (receptor of GDNF and related family members) or TrkB (BDNF receptor). Surprisingly, these mice survive to adulthood and show normal development and maturation of the nigrostriatal system. However, in ageing mice, ablation of Ret leads to a progressive and cell-type–specific loss of substantia nigra pars compacta neurons and their projections into the striatum. Our findings establish Ret and subsequent downstream effectors as critical regulators of long-term maintenance of the nigrostriatal system.Keywords
This publication has 59 references indexed in Scilit:
- Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigraThe FASEB Journal, 2005
- TrkB regulates neocortex formation through the Shc/PLCγ-mediated control of neuronal migrationThe EMBO Journal, 2004
- Factors promoting survival of mesencephalic dopaminergic neuronsCell and tissue research, 2004
- Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter regionBiochemical and Biophysical Research Communications, 2004
- Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their TargetsJournal of Neuroscience, 2004
- Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain genePitx3Development, 2004
- Novel functions and signalling pathways for GDNFJournal of Cell Science, 2003
- Parkinson's DiseaseNeuron, 2003
- Regulation of Natural Cell Death in Dopaminergic Neurons of the Substantia Nigra by Striatal Glial Cell Line-Derived Neurotrophic FactorIn VivoJournal of Neuroscience, 2003
- Targeting programmed cell death in neurodegenerative diseasesNature Reviews Neuroscience, 2003